Download PDF
kleintier konkret 2022; 25(05): 35-45
DOI: 10.1055/a-1809-0790
Innere Medizin

Kanine Babesiose – Teil 2: Co-Infektionen, Therapie, Management und Prävention

Catharina Cynthia Euler
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Die kanine Babesiose, die noch vor wenigen Jahren zu den typischen Reisekrankheiten zählte, tritt zunehmend auch autochthon in Deutschland auf. Informieren Sie sich über den aktuellen Wissensstand zu den Themen Co-Infektionen, Therapie, Management und Prophylaxe der kaninen Babesiose in Deutschland.

Publication History

Article published online:
25 October 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Zahler M, Rinder H, Schein E. et al. Detection of a new pathogenic Babesia microti-like species in dogs. Vet Parasitol 2000; 89 (03) 241-248
    CrossrefPubMedGoogle Scholar
  • 2 Zahler M, Rinder H, Zweygarth E. et al. Babesia gibsoni of dogs from North America and Asia belong to different species. Parasitology 2000; 120 (04) 365-369
    CrossrefPubMedGoogle Scholar
  • 3 Beck R, Vojta L, Mrljak V. et al. Diversity of Babesia and Theileria species in symptomatic and asymptomatic dogs in Croatia. Int J Parasitol 2009; 39 (07) 843-848
    CrossrefPubMedGoogle Scholar
  • 4 Strobl A, Pantchev N, Martin L. et al. Co-infection with Babesia canis and Babesia gibsoni in a dog. Acta Vet Hung 2021; DOI: 10.1556/004.2021.00048.
    CrossrefPubMedGoogle Scholar
  • 5 Miro G, Checa R, Paparini A. et al. Theileria annae (syn. Babesia microti-like) infection in dogs in NW Spain detected using direct and indirect diagnostic techniques: clinical report of 75 cases. Parasit Vectors 2015; 8: 217
    CrossrefPubMedGoogle Scholar
  • 6 Matjila PT, Leisewitz AL, Jongejan F. et al. Molecular detection of tick-borne protozoal and ehrlichial infections in domestic dogs in South Africa. Vet Parasitol 2008; 155: 152-157
    CrossrefPubMedGoogle Scholar
  • 7 Solano-Gallego L, Capri A, Pennisi MG. et al. Acute febrile illness is associated with Rickettsia spp infection in dogs. Parasit Vectors 2015; 8: 216
    CrossrefPubMedGoogle Scholar
  • 8 Vercammen F, De Deken R, Maes L. Clinical and serological observations on experimental infections with Babesia canis and its diagnosis using the IFAT. Parasite 1995; 2: 407-410
    PubMedGoogle Scholar
  • 9 Di Cicco MF, Downey ME, Beeler E. et al. Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin. Vet Parasitol 2012; 187: 23-27
    CrossrefPubMedGoogle Scholar
  • 10 Lin EC, Chueh LL, Lin CN. et al. The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni . Vet Parasitol 2012; 186: 159-164
    CrossrefPubMedGoogle Scholar
  • 11 Vercammen F, De Deken R, Maes L. Prophylactic treatment of experimental canine babesiosis (Babesia canis) with doxycycline. Vet Parasitol 1996; 66: 251-255
    CrossrefPubMedGoogle Scholar
  • 12 Lin MY, Huang HP. Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni . Acta Vet Scand 2010; 52: 27
    CrossrefPubMedGoogle Scholar
  • 13 Ayoob AL, Hackner SG, Prittie J. Clinical management of canine babesiosis,. J Vet Emerg Crit Care (San Antonio) 2010; 20 (01) 77-89
    CrossrefPubMedGoogle Scholar
  • 14 Aktas M, Vinclair P, Lefebvre HP. et al. In vivo quantification of muscle damage in dogs after intramuscular administration of drugs. Br Vet J 1995; 151 (02) 189-196
    CrossrefPubMedGoogle Scholar
  • 15 Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989–1999). J Am Vet Med Assoc 2001; 218: 543-546
    CrossrefPubMedGoogle Scholar
  • 16 Scott-Moncrieff JC, Treadwell NG, McCullough SM. et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001; 37: 220-227
    CrossrefPubMedGoogle Scholar
  • 17 Kidd L, Mackman N. Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia. J Vet Emerg Crit Care (San Antonio) 2013; 23: 3-13
    CrossrefPubMedGoogle Scholar
  • 18 Solano-Gallego L, Baneth G. Babesiosis in dogs and cats – expanding parasitological and clinical spectra. Vet Parasitol 2011; 181: 48-60
    CrossrefPubMedGoogle Scholar
  • 19 Irwin PJ. Canine babesiosis: from molecular taxonomy to control. Parasit Vectors 2009; Suppl 1(Suppl 1): S4
    CrossrefPubMedGoogle Scholar
  • 20 Bourdoiseau G. Canine babesiosis in France. Vet Parasitol 2006; 138: 118-125
    CrossrefPubMedGoogle Scholar
  • 21 Eichenberger RM, Riond B, Willi B. et al. Prognostic markers in acute Babesia canis infections. J Vet Intern Med 2016; 30: 174-182
    CrossrefPubMedGoogle Scholar
  • 22 Brandao LP, Hagiwara MK, Myiashiro SI. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate. Vet Parasitol 2003; 114: 253-265
    CrossrefPubMedGoogle Scholar
  • 23 Jefferies R, Ryan UM, Jardine J. et al. Blood, Bull Terriers and Babesiosis: further evidence for direct transmission of Babesia gibsoni in dogs. Aust Vet J 2007; 85: 459-463
    CrossrefPubMedGoogle Scholar
  • 24 Birkenheuer AJ, Levy MG, Breitschwerdt EB. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 2004; 18: 494-498
    CrossrefPubMedGoogle Scholar
  • 25 Birkenheuer AJ. Detection and molecular characterization of a novel large Babesia species in a dog. Vet Parasitol 2004; 124(3 – 4): 151-160
    CrossrefPubMedGoogle Scholar
  • 26 ESCCAP. Bekämpfung von Ektoparasiten (Flöhe, Zecken, Läuse, Haarlinge, Sand- und Stechmücken) bei Hunden und Katzen. Deutsche Adaption der ESCCAP-Empfehlung Nr. 3, Februar 2022. Im Internet (Stand: August 2022): https://www.esccap.org/uploads/docs/yc6cp5ga_22022EktoparasitenEmpfehlung3.pdf
    Google Scholar
  • 27 Universität Leipzig. Vetidata – Veterinärmedizinischer Informationsdienst für Arzneimittelanwendung, Toxikologie und Arzneimittelrecht in Kooperation mit dem Bundesministerium für Verbraucherschutz und Lebensmittelsicherheit. Im Internet: https://vetidata.de
    Google Scholar
  • 28 Taenzler J, Liebenberg J, Roepke RKA. et al. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto ™). Parasit Vectors 2015; 8: 305-311
    CrossrefPubMedGoogle Scholar
  • 29 Beck W. Update zur Ektoparasitenbekämpfung. Veterinärspiegel 2021; 31: 56-64
    Google Scholar
  • 30 Halos L, Baneth G, Beugnet F. et al. Defining the concept of ‚tick repellency‘ in veterinary medicine. Parasitol 2012; 139: 419-423
    CrossrefPubMedGoogle Scholar
  • 31 Eckert J, Deplazes P. Vakzinen gegen Parasiten bei Haustieren. Tierarztl Prax 1996; 24: 322-329
    PubMedGoogle Scholar
  • 32 Moreau Y, Vidor E, Bissuel G. et al. Vaccination against canine babesiosis: an overview of field observations. Trans R Soc Trop Med Hyg 1989; 83 (Suppl) 95-96
    CrossrefPubMedGoogle Scholar
  • 33 Schetters TP, Kleuskens JA, Scholtes NC. et al. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis. Vet Parasitol 1994; 52: 219-233
    CrossrefPubMedGoogle Scholar
  • 34 Schetters TP, Kleuskens JA, Scholtes NC. et al. Vaccination of dogs against Babesia canis infection. Vet Parasitol 1997; 73: 35-41
    CrossrefPubMedGoogle Scholar
  • 35 Schetters T. Vaccination against canine babesiosis. Trends Parasitol 2005; 21: 179-184
    CrossrefPubMedGoogle Scholar
  • 36 Schetters TP, Moubri K, Cooke BM. Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review. J S Afr Vet Assoc 2009; 80: 75-78
    CrossrefPubMedGoogle Scholar
  • 37 Fukumoto S, Tamaki Y, Okamura M. et al. Primeboost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs. Vaccine 2007; 25: 1334-1341
    CrossrefPubMedGoogle Scholar
  • 38 Fukumoto S, Tamaki Y, Igarashi I. et al. Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs. Exp Parasitol 2009; 123: 296-301
    CrossrefPubMedGoogle Scholar
  • 39 Eckert J, Friedhoff KT, Zahner H, Deplazes P. Lehrbuch der Parasitologie für die Tiermedizin. Stuttgart: Enke; 2005
    CrossrefGoogle Scholar
  • 40 Uilenberg G, Verdiesen PA, Zwart D. Imidocarb: a chemoprophylactic experiment with Babesia canis . Vet Q 1981; 3: 118-123
    CrossrefPubMedGoogle Scholar
  • 41 Vercammen F, De Deken R, Maes L. Clinical and serological observations on experimental infections with Babesia canis and ist diagnosis using the IFAT. Parasite 1995; 2: 407-410
    PubMedGoogle Scholar
  • 42 Wozniak EJ, Barr BC, Thomford JW. et al. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris). J Parasitol 1997; 83: 692-699
    CrossrefPubMedGoogle Scholar
  • 43 Trotta M, Carli E, Novari G. et al. Clinicopathological findings, molecular detection and characterization of Babesia gibsoni infection in a sick dog from Italy. Vet Parasitol 2009; 165: 318-322
    CrossrefPubMedGoogle Scholar
  • 44 Boozer L, Macintire D. Babesia gibsoni: An emerging pathogen in dogs. Compendium on Continuing Education for the Practising Veterinarian – North American Edition 2005; 27 (01) 33-42
    Google Scholar
  • 45 Mierzejewska EJ, Welc-Faleciak R, Bednarska M. et al. The first evidence for vertical transmission of Babesia canis in a litter of Central Asian Shepherd dogs. Ann Agric Environ Med 2014; 21 (03) 500-503
    CrossrefPubMedGoogle Scholar
  • 46 Jeagley TJ, Reichard MV, Hempstead JE. et al. Detection of Babesia gibsoni and the canine small Babesia ‘Spanish isolate’ in blood samples obtained from dogs confiscated from dogfighting operations. J Am Vet Med Assoc 2009; 235: 535-539
    CrossrefPubMedGoogle Scholar
  • 47 Birkenheuer AJ, Levy MG, Breitschwerdt EB. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 2004; 18: 494-498
    CrossrefPubMedGoogle Scholar
  • 48 Birkenheuer AJ, Levy MG, Stebbins M. et al. Serosurvey of anti-Babesia antibodies in stray dogs and American pit bull terriers and American staffordshire terriers from North Carolina. J Am Anim Hosp Assoc 2003; 39: 551-557
    CrossrefPubMedGoogle Scholar
  • 49 Springer A, Strube C. Buntzecken in Deutschland. Dt Tierärztebl 2021; 69 (01) 20-23
    Google Scholar
  • 50 Beck S, Schein E, Baldermann C. et al. Zeckeninfestation und Zeckenprophylaxe bei Hunden im Raum Berlin/Brandenburg – Ergebnisse einer Fragebogenstudie. Berl Münch Tierärztl Wochenschr 2013; 126: 69-76
    PubMedGoogle Scholar